Cargando…

Glycan targeting nanoparticle for photodynamic immunotherapy of melanoma

Interaction between tumour cells and macrophages enables cancer cells to evade immune detection and clearance by interfering with macrophage phagocytosis. The anti-phagocytic signals regulated by anti-phagocytic proteins are termed “don't eat me” signals; these signals include sialic acid-bindi...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yonghyun, Son, Wooic, Han, Youngpin, Chae, Jayoung, Yang, Chul-Su, Choi, Jonghoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213772/
https://www.ncbi.nlm.nih.gov/pubmed/37250157
http://dx.doi.org/10.1016/j.apsb.2022.08.009
_version_ 1785047699376046080
author Choi, Yonghyun
Son, Wooic
Han, Youngpin
Chae, Jayoung
Yang, Chul-Su
Choi, Jonghoon
author_facet Choi, Yonghyun
Son, Wooic
Han, Youngpin
Chae, Jayoung
Yang, Chul-Su
Choi, Jonghoon
author_sort Choi, Yonghyun
collection PubMed
description Interaction between tumour cells and macrophages enables cancer cells to evade immune detection and clearance by interfering with macrophage phagocytosis. The anti-phagocytic signals regulated by anti-phagocytic proteins are termed “don't eat me” signals; these signals include sialic acid-binding immunoglobulin-type lectin-10 (Siglec-10) and the recently revealed CD24 immune checkpoint (ICP). In this study, we demonstrate that targeting a specific glycan on CD24 exhibits the potential to inhibit ICP. Sambucus nigra agglutinin (SNA), a sialic acid-binding lectin, was employed to block CD24 and to enhance phagocytosis in melanoma tumours. In addition, we prepared SNA-conjugated hollow gold-iron oxide nanoparticles for photothermal therapy of tumours. Our findings show that the combination treatment of SNA-conjugated photothermal nanoparticles and near-infrared exposure successfully augments tumour cell phagocytosis both in vitro and in vivo models.
format Online
Article
Text
id pubmed-10213772
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102137722023-05-27 Glycan targeting nanoparticle for photodynamic immunotherapy of melanoma Choi, Yonghyun Son, Wooic Han, Youngpin Chae, Jayoung Yang, Chul-Su Choi, Jonghoon Acta Pharm Sin B Original Article Interaction between tumour cells and macrophages enables cancer cells to evade immune detection and clearance by interfering with macrophage phagocytosis. The anti-phagocytic signals regulated by anti-phagocytic proteins are termed “don't eat me” signals; these signals include sialic acid-binding immunoglobulin-type lectin-10 (Siglec-10) and the recently revealed CD24 immune checkpoint (ICP). In this study, we demonstrate that targeting a specific glycan on CD24 exhibits the potential to inhibit ICP. Sambucus nigra agglutinin (SNA), a sialic acid-binding lectin, was employed to block CD24 and to enhance phagocytosis in melanoma tumours. In addition, we prepared SNA-conjugated hollow gold-iron oxide nanoparticles for photothermal therapy of tumours. Our findings show that the combination treatment of SNA-conjugated photothermal nanoparticles and near-infrared exposure successfully augments tumour cell phagocytosis both in vitro and in vivo models. Elsevier 2023-05 2022-08-18 /pmc/articles/PMC10213772/ /pubmed/37250157 http://dx.doi.org/10.1016/j.apsb.2022.08.009 Text en © 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Choi, Yonghyun
Son, Wooic
Han, Youngpin
Chae, Jayoung
Yang, Chul-Su
Choi, Jonghoon
Glycan targeting nanoparticle for photodynamic immunotherapy of melanoma
title Glycan targeting nanoparticle for photodynamic immunotherapy of melanoma
title_full Glycan targeting nanoparticle for photodynamic immunotherapy of melanoma
title_fullStr Glycan targeting nanoparticle for photodynamic immunotherapy of melanoma
title_full_unstemmed Glycan targeting nanoparticle for photodynamic immunotherapy of melanoma
title_short Glycan targeting nanoparticle for photodynamic immunotherapy of melanoma
title_sort glycan targeting nanoparticle for photodynamic immunotherapy of melanoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213772/
https://www.ncbi.nlm.nih.gov/pubmed/37250157
http://dx.doi.org/10.1016/j.apsb.2022.08.009
work_keys_str_mv AT choiyonghyun glycantargetingnanoparticleforphotodynamicimmunotherapyofmelanoma
AT sonwooic glycantargetingnanoparticleforphotodynamicimmunotherapyofmelanoma
AT hanyoungpin glycantargetingnanoparticleforphotodynamicimmunotherapyofmelanoma
AT chaejayoung glycantargetingnanoparticleforphotodynamicimmunotherapyofmelanoma
AT yangchulsu glycantargetingnanoparticleforphotodynamicimmunotherapyofmelanoma
AT choijonghoon glycantargetingnanoparticleforphotodynamicimmunotherapyofmelanoma